Isolation, in vitro study, and stem cell markers for type A spermatogonia in a Characiformes species

2020 ◽  
Vol 87 (7) ◽  
pp. 783-799
Author(s):  
Gisele C. M. Dias ◽  
Sérgio R. Batlouni ◽  
Mônica Cassel ◽  
Chayrra Chehade ◽  
Lázaro W. O. De Jesus ◽  
...  
2020 ◽  
Vol 11 (2) ◽  
pp. 224-230
Author(s):  
Vijay M. Kumbar ◽  
Uday M. Muddapur ◽  
Kishore G. Bhat ◽  
Shwetha H.R. ◽  
Manohar S. Kugaji ◽  
...  

Aim: The cancer stem cells (CSCs) are known to be responsible for drug resistance and cancer relapse in the treatment of cancer. Identification and isolation of CSCs and study of their properties will play a crucial role in developing an effective drug against these targets. The aim of the study was to isolate CSCs from primary cancer by the tumorspheres enrichment method, to confirm by indirect immunofluorescence and gene expression of stem cell markers by using real-time polymerase chain reaction (RT-PCR) technique. Materials and Methods: In this in vitro study, we enriched oral CSCs through tumorsphere formation assay from seven primary cultures of OSCC patients with defined serum media. The expression and localization of the cell surface markers of CD133 and CD44 were tested by indirect immunofluorescence. Gene expression of stem cell markers such as CD44, CD133, Oct4, Sox2, and Nanog were quantified by RT-PCR technique. One-way analysis of variance was applied to analyze gene expression. Results: Tumorsphere formation has been used to isolate the CSCs from the OSCC tissue culture. Both CD133 and CD44 antibody confirmed the presence of CSCs through indirect immunofluorescence. In comparison to parental cell lines, the expression levels of CD133, CD44, Oct4, Sox2, and Nanog stem cell were significantly higher in CSC-enriched subpopulations. Conclusions: The cost-effective spheroid enrichment and the indirect immunofluorescence methods are useful for the isolation of CSCs from the primary tumor.


2019 ◽  
Vol 18 (5) ◽  
pp. 1215-1223 ◽  
Author(s):  
Rungsima Wanitphakdeedecha ◽  
Arisa Kaewkes ◽  
Chanida Ungaksornpairote ◽  
Saowalak Limsaengurai ◽  
Uraiwan Panich ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Laura L. Stafman ◽  
Adele P. Williams ◽  
Raoud Marayati ◽  
Jamie M. Aye ◽  
Hooper R. Markert ◽  
...  

Abstract Patient-derived xenografts (PDXs) provide an opportunity to evaluate the effects of therapies in an environment that more closely resembles the human condition than that seen with long-term passage cell lines. In the current studies, we investigated the effects of FAK inhibition on two neuroblastoma PDXs in vitro. Cells were treated with two small molecule inhibitors of FAK, PF-573,228 (PF) and 1,2,4,5-benzentetraamine tetrahydrochloride (Y15). Following FAK inhibition, cell survival and proliferation decreased significantly and cell cycle arrest was seen in both cell lines. Migration and invasion assays were used to determine the effect of FAK inhibition on cell motility, which decreased significantly in both cell lines in the presence of either inhibitor. Finally, tumor cell stemness following FAK inhibition was evaluated with extreme limiting dilution assays as well as with immunoblotting and quantitative real-time PCR for the expression of stem cell markers. FAK inhibition decreased formation of tumorspheres and resulted in a corresponding decrease in established stem cell markers. FAK inhibition decreased many characteristics of the malignant phenotype, including cancer stem cell like features in neuroblastoma PDXs, making FAK a candidate for further investigation as a potential target for neuroblastoma therapy.


2011 ◽  
Vol 150 (4) ◽  
pp. 535-542 ◽  
Author(s):  
I. A. Khlusov ◽  
M. Yu. Khlusova ◽  
K. V. Zaitsev ◽  
T. D. Kolokol’tsova ◽  
Yu. P. Sharkeev ◽  
...  

2012 ◽  
Vol 38 (10) ◽  
pp. 1689-1694 ◽  
Author(s):  
Sang-Ha Oh ◽  
Young Lee ◽  
Young-Joon Seo ◽  
Jeung-Hoon Lee ◽  
Jung D. Yang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document